Evommune, Inc. (EVMN) ownership: Top institutional holder: EQT Fund Management S.a r.l. ($113.33M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| EQT Fund Management S.a r.l. | 4929633.00 | $113.33M | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 3494638.00 | $80.34M | 2026-03-31 |
| Pivotal bioVenture Partners Investment Advisor LLC | 1926943.00 | $44.30M | 2026-03-31 |
| ANDERA PARTNERS | 1897362.00 | $43.62M | 2026-03-31 |
| RTW INVESTMENTS, LP | 1502235.00 | $34.54M | 2026-03-31 |
| MPM BIOIMPACT LLC | 1455863.00 | $33.47M | 2026-03-31 |
| Nan Fung Group Holdings Ltd | 1441032.00 | $33.13M | 2026-03-31 |
| JPMORGAN CHASE & CO | 1459420.00 | $32.11M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-06-01 |
Back to EVMN overview · EVMN earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.